tradingkey.logo
tradingkey.logo
Search

Bicycle Therapeutics PLC

BCYC
Add to Watchlist
3.740USD
+0.110+3.03%
Market hours 09/22, 11:41ET
188.41MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+3.03%

5 Days

-3.86%

1 Month

-14.42%

6 Months

-14.02%

Year to Date

-47.18%

1 Year

-46.03%

Key Figures

3.685Open
3.830High
44.90KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.09%Turnover Ratio
3.630Prev. Close
3.680Low
169.68KTurnover
LossP/E Static
0.37P/B
0.00%Div Yield TTM
-28.51%ROA
9.15952wk High
0.36Volume Ratio
-169.03MNet Profit
50.38MShares
-3.1554EPS TTM
1.55Beta
-33.84%ROE
3.60552wk Low
4.13%Amplitude
100.00%Gross Margin
188.41MMarket Cap
-2.07Reward/Risk
3.25%Risk Rate
More news coming soon, stay tuned...

Bicycle Therapeutics PLC's Score

-0.13vs previous score
Forecast8.00
Financial Health6.32
Technical4.17
Valuation Dimensions8.12
Institutional Confidence5.00
Risk Assessment4.79

Media Coverage

Coverage Level

Very Low
Very High
Neutral

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
10.143Target Price
+177.89%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy33444444
Buy44444455
Hold33345555
Sell00000000
Strong Sell00000000

Bicycle Therapeutics PLC Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Neutral

Summary

Sell

Moving Average

Strong sell

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.72/-0.58
Revenue / Forecast
629.00K/4.22M

Bicycle Therapeutics PLC Profile

SectorBiotechnology & Medical Research
Ticker SymbolBCYC
Number of employees305
CountryUnited Kingdom

Ownership

ShareholdersProportion
Baker Bros. Advisors LP21.68%
Forbion Capital Partners6.89%
Armistice Capital LLC6.42%
Acadian Asset Management LLC3.32%
Shareholder TypesProportion
Hedge Fund36.92%
Investment Advisor14.08%
Investment Advisor/Hedge Fund7.12%
Venture Capital7.12%

FAQs

What is the current price of Bicycle Therapeutics PLC (BCYC)?

The current price of Bicycle Therapeutics PLC (BCYC) is 3.63.

What is the symbol of Bicycle Therapeutics PLC?

The ticker symbol of Bicycle Therapeutics PLC is BCYC.

What is the 52-week high of Bicycle Therapeutics PLC?

The 52-week high of Bicycle Therapeutics PLC is 9.16.

What is the 52-week low of Bicycle Therapeutics PLC?

The 52-week low of Bicycle Therapeutics PLC is 3.60.

What is the market capitalization of Bicycle Therapeutics PLC?

The market capitalization of Bicycle Therapeutics PLC is 183.37M.

Is Bicycle Therapeutics PLC (BCYC) currently rated as Buy, Hold, or Sell?

According to analysts, Bicycle Therapeutics PLC (BCYC) has an overall rating of Buy, with a price target of 10.14.

What is the Earnings Per Share (EPS TTM) of Bicycle Therapeutics PLC (BCYC)?

The Earnings Per Share (EPS TTM) of Bicycle Therapeutics PLC (BCYC) is -3.16.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.